BE896274A - Nouvelle utilisation d'analogues de prostaglandines - Google Patents

Nouvelle utilisation d'analogues de prostaglandines

Info

Publication number
BE896274A
BE896274A BE0/210404A BE210404A BE896274A BE 896274 A BE896274 A BE 896274A BE 0/210404 A BE0/210404 A BE 0/210404A BE 210404 A BE210404 A BE 210404A BE 896274 A BE896274 A BE 896274A
Authority
BE
Belgium
Prior art keywords
new use
prostaglandin analogs
prostaglandin
analogs
new
Prior art date
Application number
BE0/210404A
Other languages
English (en)
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of BE896274A publication Critical patent/BE896274A/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Materials Engineering (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
BE0/210404A 1982-03-25 1983-03-25 Nouvelle utilisation d'analogues de prostaglandines BE896274A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP57046380A JPS58164512A (ja) 1982-03-25 1982-03-25 プロスタグランジン類似化合物を有効成分として含有する肝臓疾患治療剤

Publications (1)

Publication Number Publication Date
BE896274A true BE896274A (fr) 1983-09-26

Family

ID=12745531

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/210404A BE896274A (fr) 1982-03-25 1983-03-25 Nouvelle utilisation d'analogues de prostaglandines

Country Status (4)

Country Link
US (1) US4464388A (fr)
JP (1) JPS58164512A (fr)
BE (1) BE896274A (fr)
DE (1) DE3310556A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562207A (en) * 1983-03-08 1985-12-31 Ono Pharmaceutical Co., Ltd. Prostaglandin analogue

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6130554A (ja) * 1984-07-23 1986-02-12 Ono Pharmaceut Co Ltd プロスタグランジン類似化合物のある特定の立体配置を有する異性体及びそれらを有効成分として含有する治療剤
DE3427797A1 (de) * 1984-07-25 1986-02-06 Schering AG, 1000 Berlin und 4709 Bergkamen Zytoprotektive wirkung von prostacyclin-derivaten an leber, bauchspeicheldruese und niere
CA2027814C (fr) * 1989-10-20 1996-07-30 Ryuji Ueno Traitement d'une maladie hepatobiliaire a base de composes 5-cetoprostaglandin
US5256696A (en) * 1989-11-22 1993-10-26 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of cardiac dysfunction with 15-ketoprostaglandin compounds
US5254588A (en) * 1989-11-22 1993-10-19 Kabushikikaisha Ueno Seiyaku Oyo Kenkyujo Treatment of pulmonary dysfunction with 15-ketoprostaglandin compounds
CA2030344C (fr) 1989-11-22 2000-04-18 Ryuji Ueno Traitement de troubles pulmonaires a l'aide de composes de 15-ceto-prostaglandines
US5380667A (en) * 1992-10-30 1995-01-10 The United States Of America As Represented By The Secretary Of The Air Force Serum bilirubin and liver function tests as risk predictors for coronary artery disease
CA2150287C (fr) 1994-06-03 2004-08-10 Ryuji Ueno Agent therapeutique pour les affections hepatobiliaires
CA2254925A1 (fr) * 1997-03-13 1998-09-17 Shigeyasu Annoh Medicament pour traiter les lesions vasculaires diabetiques
US6340693B1 (en) 1997-03-14 2002-01-22 Toray Industries, Inc. Protective agent for nervous system structural cells
AU782869B2 (en) 1999-08-05 2005-09-08 Teijin Limited Neuropathy improvers containing nitrogenous compounds as the active ingredient
DE10160935A1 (de) * 2001-12-12 2003-07-17 Daimler Chrysler Ag Kraftfahrzeugkühlvorrichtung für elektronische Geräte
CN103238070B (zh) * 2010-10-01 2016-06-29 丹麦国家医院 能够调节/保护内皮完整性的用于预防或治疗急性创伤性凝血病和心脏骤停复苏的化合物

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081553A (en) * 1976-02-17 1978-03-28 The Upjohn Company Cytoprotective prostaglandins for use in human intestinal diseases
US4083998A (en) * 1976-02-17 1978-04-11 The Upjohn Company Treatment of inflammatory diseases of the mammalian large intestine with cytoprotective prostaglandins
JPS5395958A (en) * 1977-01-31 1978-08-22 Ono Pharmaceut Co Ltd Prostaglandin analogues and process for their preparation
US4178367A (en) * 1977-02-21 1979-12-11 Ono Pharmaceutical Co. Ltd. Prostaglandin I2 analogues
US4097603A (en) * 1977-09-06 1978-06-27 The Upjohn Company Gastric cytoprotection with non-antisecretory doses of prostaglandins
JPS6022710B2 (ja) * 1977-09-16 1985-06-03 小野薬品工業株式会社 プロスタグランジン類似化合物
JPS5452069A (en) * 1977-09-29 1979-04-24 Ono Pharmaceut Co Ltd Prostaglandin i2 analog compound and its preparation
JPS54125653A (en) * 1978-03-18 1979-09-29 Ono Pharmaceut Co Ltd Prostaglandin i2 analog, its preparation, and drug composition comprising it as active constituent
DE2947526A1 (de) * 1978-11-29 1980-06-12 Ono Pharmaceutical Co Prostacyclin-analoge

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4562207A (en) * 1983-03-08 1985-12-31 Ono Pharmaceutical Co., Ltd. Prostaglandin analogue

Also Published As

Publication number Publication date
JPH0227970B2 (fr) 1990-06-20
US4464388A (en) 1984-08-07
DE3310556C2 (fr) 1991-07-11
DE3310556A1 (de) 1983-11-24
JPS58164512A (ja) 1983-09-29

Similar Documents

Publication Publication Date Title
BE896274A (fr) Nouvelle utilisation d'analogues de prostaglandines
IT1177013B (it) Analoghi interfenilene di prostaglandina 7-ossa-biciclo eptano sostituiti
FR2539129B1 (fr) Analogues amines des prostaglandines 7-oxabicycloheptane-substitues utiles comme medicaments cardio-vasculaires
YU158087A (en) Mechanism for rerouting of multiprocessor interrupts
KR890700600A (ko) 펩타이드 유사체의 합성
IT1161242B (it) Analoghi di prostaglandina 7-ossabicicloeptanidrazone
DE3363460D1 (de) Carbacyclin analogues
ES548238A0 (es) Procedimiento para preparar analogos de adenosinas n6 susti-tuidas
FR2574794B1 (fr) Analogues de prostaglandines tetrahydrothienyl-substitues a action cardiovasculaire
BE896818A (fr) Nouvelle utilisation d'analogues des prostaglandines.
IT1173442B (it) Analoghi di prostaglandina 7-ossabicicloeptano sostituito
GB8722764D0 (en) Hydroxamic acid prostaglandin analogs
FR2525215B1 (fr) Analogues de la vasopressine
IT1176632B (it) Analoghi di prostaglandine di tiocarbammati 7-ossabicicloeptano sostituiti
GB2153352B (en) Prostaglandin analogs
IT1204769B (it) Analoghi di ossaprostaglandina 7-ossabicicloeptano sostituiti
ES553549A0 (es) Un procedimiento para la preparacion de nuevos analogos de mitomicina
GB8710728D0 (en) Amido-carbamoyl prostaglandin analogs
IT8347945A0 (it) Apparecchiatura per la calcinazione di coke
IT1164157B (it) 6'alchil analoghi della spectinomicina a metodi per la loro preparazione
ES273575Y (es) Andamiaje de albanileria
BE896943A (fr) Analogues d'hormones neurohypophysaires exercant des effets inhibiteurs
IT8321335A1 (it) Analoghi della prostaglandina
FR2526318B1 (fr) Analogues d'hormones neurohypophysaires ayant des proprietes inhibitrices
IT8222515A1 (it) Nuovi esteri dell'epinina

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ONO PHARMACEUTICAL CO. LTD

Effective date: 19910331